Cohere Health, a clinical intelligence company, has secured $90 million in Series C funding to accelerate the growth of its clinical intelligence platform for health plans and risk-bearing providers.
Here are five things to know:
- The round was led by Temasek, with participation from Deerfield Management, Define Ventures, Flare Capital Partners, Longitude Capital and Polaris Partners. This brings the company’s total funding to $200 million, according to a May 14 press release.
- The new capital will support scaling the Cohere Unify platform, expanding to new clinical use cases, and investing in AI-powered product development.
- Cohere Unify modernizes utilization management by integrating real-time provider performance data, automating prior authorizations, and supporting clinical decision-making with precision insights.
- The company processes over 12 million prior authorization requests annually for more than 600,000 providers nationwide.
- Cohere’s platform enables up to 90% of requests to be auto-approved, helping reduce provider burden and expedite patient care.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
